InvestorsHub Logo
Followers 11
Posts 292
Boards Moderated 0
Alias Born 03/11/2011

Re: None

Thursday, 11/19/2015 6:39:24 PM

Thursday, November 19, 2015 6:39:24 PM

Post# of 48316
Melanoma CME has a lecture on IL-12 Electroporation supported by a grant from Merck.


LECTURE

•Plasmid IL-12 Electroporation in Melanoma





Provider Statement: This continuing medical education activity is provided by Vindico Medical Education.

Support Statement: This activity is supported by an educational grant from Merck and Co., Inc.

Target Audience: The intended audience for the activities is medical oncologists, surgical oncologists, dermatologists, oncology nurses, nurse practitioners, physician assistants and other healthcare professionals involved in the treatment of patients with melanoma.

Learning Objectives: Upon successful completion of this educational activity, participants should be better able to assess the value of plasmid IL-12 electroporation in treating patients with advanced melanoma.



Faculty:
Alain Algazi, MD
Assistant Professor
UCSF Melanoma Oncology
UCSF Helen Diller Family
Comprehensive Cancer Center
San Francisco, California

Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.